Optivia Biotechnology Inc. Wins CRO Leadership Award from Life Science Leader
6/4/2012 10:54:21 AM
More...
|
Optivia Biotechnology Inc. Awarded $1.85 Million SBIR Grant to Build Comprehensive Platform for Assessing Dangerous Drug-Drug Interactions
4/5/2011 10:45:33 AM
More...
|
Almost 300 New Jobs To Be Created By Three Pharma Firms: Optivia Biotechnology Inc., Global Research Services, LLC, and International Prevention Research Institute (iPRI)
3/16/2011 6:06:04 PM
More...
|
Optivia Biotechnology Inc. Signs Agreement With U.S. FDA to Assess Role of Dietary Supplements in Drug-Induced Liver Injury
2/1/2011 9:00:33 AM
More...
|
University of California, San Francisco (UCSF) and Optivia Biotechnology Inc. Collaborate to Predict Liver Toxicity of Drugs in Development
11/16/2010 9:57:40 AM
More...
|
Optivia Biotechnology Inc. Names Dr. Yuichi Sugiyama to Scientific Advisory Board
11/15/2010 11:59:26 AM
More...
|
Optivia Biotechnology Inc. Launches Comprehensive Assay Suite to Assess Transporter-Related Drug-Drug Interactions and Improve Drug Safety
5/11/2010 11:15:17 AM
More...
|